Medication for Opioid Use Disorder During Pregnancy — Maternal and Infant Network to Understand Outcomes Associated with Use of Medication for Opioid Use Disorder During Pregnancy (MAT-LINK), 2014–2021

PROBLEM: Medication for opioid use disorder (MOUD) is recommended for persons with opioid use disorder (OUD) during pregnancy. However, knowledge gaps exist about best practices for management of OUD during pregnancy and these data are needed to guide clinical care. PERIOD COVERED: 2014–2021. DESCRI...

Descripción completa

Detalles Bibliográficos
Autores principales: Miele, Kathryn, Kim, Shin Y., Jones, Rachelle, Rembert, Juneka H., Wachman, Elisha M., Shrestha, Hira, Henninger, Michelle L., Kimes, Teresa M., Schneider, Patrick D., Sivaloganathan, Vaseekaran, Sward, Katherine A., Deshmukh, Vikrant G., Sanjuan, Pilar M., Maxwell, Jessie R., Seligman, Neil S., Caveglia, Sarah, Louis, Judette M., Wright, Tanner, Bennett, Carolyne Cody, Green, Caitlin, George, Nisha, Gosdin, Lucas, Tran, Emmy L., Meaney-Delman, Dana, Gilboa, Suzanne M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Centers for Disease Control and Prevention 2023
Materias:
Surveillance Summaries
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154076/
https://www.ncbi.nlm.nih.gov/pubmed/37130060
http://dx.doi.org/10.15585/mmwr.ss7203a1

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10154076/
https://www.ncbi.nlm.nih.gov/pubmed/37130060
http://dx.doi.org/10.15585/mmwr.ss7203a1

Ejemplares similares